admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Bright Minds Announces Proposed Share Consolidation

Numinus Announces Agreement with HealingMaps to Drive Strategic Clinic Growth

Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent

Navigating Psychedelics for Clinicians and Wellness Practitioners – Informational Session

Vital Breathwork Information and Q&A

Tripping Rabbis: The Psychedelic Influence on Jewish Renewal

Delix Therapeutics Announces Completion of 1st Cohort Dosing, Dose Escalation Approval...

PharmaTher and Vitruvias Enter Into Collaboration Agreement for Commercialization of KETARX™...

PT416 – A New Chapter for Johns Hopkins Psychedelic & Consciousness...

A Vital Journey: Breathwork Retreat

1...606162...218 Page 61 of 218

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin